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Abstract
Background: We present a case of amyloid light-chain amyloidosis with occult plasma cell dyscrasia, with the rare
initial presentation of gastroparesis. While amyloidosis is known to affect the gastrointestinal system, rarely do
patients present with gastrointestinal symptoms as their first symptom. To the best of our knowledge, this is the
first such case reported with a definitive diagnosis made on gastroscopy.
Case presentation: A 52-year-old Malay man with abdominal bloating, early satiety, and weight loss was found to
have significant gastroparesis. He had a past medical history of stable non-ischemic cardiomyopathy. Results from
initial screening were negative for common causes of gastroparesis, such as diabetes or offending medications.
Gastroscopy did not show any mechanical gastric outlet obstruction. Our patient subsequently developed symptoms
of postural giddiness, which then prompted further investigations for possible autonomic dysfunction. These finally
revealed evidence of systemic involvement, including postural hypotension, speckled myocardium with infiltrative
cardiomyopathy on a transthoracic echocardiogram, and multifocal motor neuropathy on nerve conduction studies,
from which he had been relatively asymptomatic. These findings were collectively suggestive of infiltrative disease.
Retrospective Congo red staining of a gastric biopsy specimen confirmed the diagnosis of gastric amyloidosis. The final
diagnosis was amyloid light-chain amyloidosis secondary to plasma cell dyscrasia, which was confirmed by bone
marrow examination. Our patients was started on chemotherapy and prokinetic agents, with some improvement in
gastrointestinal symptoms on follow-up.
Conclusion: We present this case to highlight that, although rare, gastroparesis can be the initial sole presentation of
amyloidosis. It is important for the internist, gastroenterologist, and hematologist to consider amyloidosis as a differential
diagnosis in the investigation of gastroparesis and to be vigilant in monitoring for other systemic involvement.
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Background
Delayed gastric emptying and weight loss can be the re-
sult of various causes, such as gastroparesis secondary to
autonomic dysfunction from diabetes mellitus, or mech-
anical causes such as ulcers or strictures. We describe a
rare case in which the initial presentation was that of
gastroparesis and weight loss. Subsequent extensive
investigations revealed amyloid light-chain (AL) amyl-
oidosis due to occult plasma cell dyscrasia as the cause
of our patient’s symptoms. This diagnosis may explain a
previous history of non-ischemic cardiomyopathy.
Gastrointestinal tract involvement is frequently found
on postmortem examination in AL amyloidosis, but it
causes symptoms in less than 1 % of patients [1]. We
present this case to highlight the importance of consid-
ering an infiltrative systemic disorder for gastrointestinal
symptoms and weight loss. Suspicion of amyloidosis as a
cause should be heightened if the patient has prior unex-
plained organ dysfunction, such as non-ischemic cardio-
myopathy in our patient.
Case presentation
A 52-year-old Malay man was admitted with a 7-month
history of abdominal bloating and significant weight loss
of 20 kg. He also described reflux symptoms with acid
brash, early satiety, and post-meal vomiting, occurring
30–60 minutes after meals.
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He had a past medical history of non-ischemic cardio-
myopathy diagnosed in a regional hospital in Singapore
in 2009. An electrocardiogram performed at that time
showed left ventricular hypertrophy with poor R wave
progression, with the echocardiogram showing a severely
impaired ejection fraction of 15 % and raised pulmonary
pressure. He was started on medications for cardiomy-
opathy but was subsequently lost to follow-up and
remained stable without further cardiovascular symp-
toms. He did not smoke cigarettes nor drink alcohol. A
physical examination was unremarkable except for a
vague epigastric mass on palpation.
Initial investigations revealed normochromic and
normocytic anemia with a hemoglobin level of 11.5 g/dL
(normal range, 14–17 g/dL) and albumin of 30 g/L (nor-
mal range, 35–55 g/L). Other blood investigations,
including urea, creatinine, electrolytes, liver function,
thyroid function, autoimmune screen, retroviral screen,
and random and fasting blood sugar levels, were normal.
A chest X-ray showed an enlarged gastric shadow with
evidence of food residue (Fig. 1). A computed tomog-
raphy scan of his abdomen showed that his stomach was
distended with a large amount of gastric content in spite
of 4 hours of fasting prior to the scan (Fig. 2). An initial
gastroscopy showed reflux oesophagitis and food reten-
tion but no evidence of gastric outlet obstruction from
ulcers, masses, or strictures. A small bowel series
confirmed evidence of delayed gastric emptying with
significant residual gastric barium at 20 hours (Fig. 3).
Our patient was started on the pro-kinetic agent
domperidone with little improvement in symptoms.
Three weeks from his initial presentation to our
hospital, our patient complained of postural giddiness.
Significant postural hypotension was noted, with his
blood pressure falling from 117/75 mmHg when lying to
72/32 mmHg on standing. Further questioning revealed
a history of fewer morning erections and possible anhi-
drosis with little sweating on hot days. He also had mild
weakness in his right knee extensor muscles (Medical
Research Council grade 4/5), which he attributed to
weakness from a fall sustained many years ago. Magnetic
resonance imaging of his spine showed non-significant
degenerative disc disease and a diffuse low marrow
signal on both T1 and T2 sequences, suggestive for
marrow replacement or deposition disease.
A repeat gastroscopy was done at a private hospital
with a random gastric biopsy showing chronic gastritis.
He was readmitted to our hospital for further investiga-
tions. It was noted that he had new left-sided periorbital
purpura, which had occurred after he had rubbed his
eye the day before. Autonomic function studies showed
abnormal findings in his lower limbs. Nerve conduction
studies showed evidence of left peroneal neuropathy, bi-
lateral carpal tunnel syndrome, and bilateral ulnar
neuropathy, attributed to a subclinical multifocal
motor neuropathy. Transthoracic echocardiography
showed an ejection fraction of 41 %, evidence of
biventricular hypertrophy with increased speckling of
the ventricular walls, and significant diastolic dysfunc-
tion, raising the suspicion of an infiltrative
cardiomyopathy.
With mounting evidence of a systemic disorder in-
volving autonomic dysfunction with gastroparesis and
postural hypotension, infiltrative cardiomyopathy, and
Fig. 1 Chest X-ray showing distended gastric outline with food residue
Fig. 2 Abdominal computed tomography showing distended stomach
with large amounts of gastric content in spite of 4 hours of fasting prior
to the scan
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multifocal motor neuropathy, a decision was made to
investigate further for infiltrative disorders. A repeat
histological examination of the previous gastric biopsy
was carried out at our hospital with the addition of
Congo red staining, which showed apple green bi-
refringence of amorphous material in the submucosa,
confirming the diagnosis of amyloidosis (Fig. 4).
Plasma electrophoresis showed polyclonal bands of im-
munoglobulin G, immunoglobulin M as well as lambda
and kappa light chains. Bone marrow aspirate was hypo-
cellular with erythroid and megakaryocytic hyperplasia
with moderate plasmacytosis, compatible with plasma cell
dyscrasia. Our patient was referred to our Department of
Haematology and subsequently started on chemotherapy
with bortezomib, cyclophosphamide, and dexamethasone
for AL amyloidosis secondary to a plasma cell dyscrasia.
On follow-up 2 months later, he had some improvement
in his gastrointestinal symptoms with ongoing chemother-
apy and use of pro-kinetic agents.
Discussion
Amyloidosis is a systemic disorder caused by deposition
of insoluble abnormal amyloid fibrils that alter the
normal function of tissues. The type of protein that is
misfolded and the organ or tissue in which they are
deposited determine the clinical manifestations of
amyloidosis.
The term “amyloid” was first used by Virchow to
describe an abnormal extracellular material seen in the
liver on autopsy [2]. It was later recognized that this
amyloid material uniformly appeared apple green under
polarized light with Congo red staining. Electron micros-
copy showed a common fibrillar nature and beta pleated
sheet structure that was key to the pathogenesis of
disease.
Various historical classification systems were based on
clinical findings or the distribution of organ involvement.
The modern classification system of amyloidosis is now
based on the type of precursor protein involved [3], made
possible by advances in technology that allow for chemical
characterization of each protein. The most common forms
of amyloidosis are amyloid light-chain (AL or primary sys-
temic), as was the case for our patient; amyloid A (AA or
secondary systemic); and familial (abnormal amyloid
transthyretin [ATTR]).
The global incidence of systemic amyloidosis is about
8–12 per million persons per year. The initial manifesta-
tions can be non-specific, such as weight loss or fatigue.
Gastrointestinal symptoms are relatively uncommon,
occurring in less than 1 % of patients even though post-
mortem gastrointestinal involvement can be seen in up
to 40 % of cases [4]. If involved, presentation can be
Fig. 3 Barium studies showing significant delay in gastric emptying even at 20 hours after barium ingestion, with significant residual gastric barium
Fig. 4 Gastric biopsy showing amorphous material in the submucosa
with apple green birefringence on Congo red staining under
polarized light
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with dysphagia [1], gastroparesis, pseudo-obstruction
[5], malabsorption [6], or even bowel ischemia or in-
farction [7] due to amyloid deposition in the intestinal
vascular supply. As in our patient’s case, it is rare for
a patient to present initially with such overt gastro-
intestinal symptoms.
Definitive diagnosis of amyloidosis depends on a
biopsy of the affected tissue or organ, or of rectal or sub-
cutaneous fat in systemic disease. Treatment of systemic
amyloidosis remains unsatisfactory, with a median prog-
nosis of 13 months [8]. Treatment in AL amyloidosis is
based on a regime of chemotherapy and stem cell trans-
plantation if possible. Supportive measures appropriate
to the organ systems affected can be initiated to improve
quality of life.
Conclusion
This case has highlighted that amyloidosis can initially
present with predominantly gastrointestinal symptoms
alone, with other clues to systemic involvement occur-
ring much later. Although a rare cause of gastroparesis
and weight loss, internists, gastroenterologists, and he-
matologists should consider amyloidosis as an important
differential diagnosis, and should be vigilant in monitor-
ing for later developments indicating other systemic
involvement. A high index of suspicion is required to
consider amyloidosis when other more common causes
such as autonomic dysfunction due to diabetes, malig-
nancy, or mechanical gastric outlet obstructions have
been excluded.
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